secwatch.observer — SEC 8-K summary
======================================

Issuer:     RANGE IMPACT, INC. (RNGE)
CIK:        0001438943
Form:       8-K
Filed at:   2021-09-02T23:59:59+00:00
Accession:  0001493152-21-021902
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vitality Biopharma secures $5M equity line; S-1 effective, DTC eligible
-----------------------------------------------------------------------

- SEC declared Form S-1 effective on Sept 2, 2021, registering shares for resale by Triton Funds under a $5M equity line.
- Proceeds from the equity line will fund pre-clinical studies of lead prodrug VBX-100 and general corporate purposes.
- VBX-100, a glycosylated cannabinoid, received FDA Orphan Drug Designation for pediatric ulcerative colitis.
- Common shares deemed DTC eligible effective July 1, 2021, enabling electronic clearing and settlement.
- Only Triton Funds LP may use the prospectus to resell shares under the registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438943/000149315221021902/0001493152-21-021902-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438943/000149315221021902/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-021902

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer